May 13, 2020 by James HalleyIs Now Still a Good Time To Buy Amgen?The biotech giant is back on track after a strong first quarter.
May 12, 2020 by James HalleyShould You Climb on Board the Corcept Therapeutics Train?This biotech company has seen huge growth over the past five years.
May 9, 2020 by James Halley5 Reasons Why Vapotherm Will Keep ClimbingThe company's products are getting exposure, thanks in part to the coronavirus pandemic.
May 6, 2020 by James HalleyIs It Time to Get in on GW Pharmaceuticals While the Price Is Right?It isn’t turning a profit yet, but its revenue is about to jump.
May 5, 2020 by James HalleyWhy Abiomed's Stock Price Jumped Last WeekThe company is weathering a coronavirus-related shutdown, and a new purchase will help with diversification.
May 1, 2020 by James Halley3 Healthcare Stocks With a Solid Bottom Line -- and a DividendBristol Myers Squibb, Cardinal Health, and McKesson are all underpriced.
Apr 29, 2020 by James Halley3 Healthcare Stocks With Solid Dividends to Hold Through Bumpy TimesJohnson & Johnson, AbbVie, and GlaxoSmithKline are all good choices.
Apr 28, 2020 by James HalleyQuest Diagnostics Is Set to Ride Out Coronavirus ConcernsIts first-quarter numbers show the impact of the pandemic shutdown, but investors should be thinking long term.
Apr 23, 2020 by James HalleyTrulieve Rolls Toward a Strong Position in the Pot IndustryThe company deserves a close look in a risky space.
Apr 21, 2020 by James HalleyEven After Growth, ResMed Has Plenty of Room to RunWhy the medical supply company's stock bounced back quickly after last month's dip.
